Bio-Techne Corp (FRA:TE1)
€ 76.5 1 (1.32%) Market Cap: 11.96 Bil Enterprise Value: 12.28 Bil PE Ratio: 65.48 PB Ratio: 6.45 GF Score: 92/100

Bio-Techne Corp at Cowen Health Care Conference (Virtual) Transcript

Mar 07, 2022 / 04:10PM GMT
Release Date Price: €93
Stephanie Yan
Cowen and Company, LLC, Research Division - Associate

Good morning, everyone. I'm Stephanie Yan from the Life Science Tools and Diagnostics team at Cowen. It is my pleasure to introduce Bio-Techne Corporation to our conference. I'll now pass it over to Jim Hippel, CFO, for the presentation.

James T. Hippel
Bio-Techne Corporation - Executive VP of Finance & CFO

Thank you, Stephanie. It's great to be here. Thanks for having us. Before we begin, real quickly, I'd like to mention the safe harbor cautionary statements. They will apply probably my presentation here today, and I encourage you to read these in detail in the Investors section of our website.

I will begin with a high-level overview of our company. Bio-Techne has been -- it's basically a 40-year-old life sciences tools company with mostly comprised of a kind of consumable recurring revenue stream. Our primary products have been of our core business for most of this time period. It has been the world leading provider of proteins, antibodies and immunoassay.

We

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot